Michael Edell - 09 Jun 2026 Form 4 Insider Report for SenesTech, Inc. (SNES)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Jun 2026, 20:20:42 UTC
Prior SEC filing
09 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas C. Chesterman, as Attorney-in-Fact

Key filing fact

Michael Edell filed Form 4 for SenesTech, Inc. (SNES) on 15 Jun 2026.

Key facts

  • This page summarizes Michael Edell's Form 4 filing for SenesTech, Inc. (SNES).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 15 Jun 2026, 20:20.

Change

  • Previous filing in this sequence was filed on 09 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001300316 Primary reporting owner

Edell Michael

Relationship
Chief Executive Officer, Director
Address
13430 N DYSART RD STE 105, SURPRISE
Signature
/s/ Thomas C. Chesterman, as Attorney-in-Fact
Signature date
15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNES transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+263,288
Change %
Price
$0.000000*
Shares after
263,288
Date
09 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
263,288
Exercise price
$1.47
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Same as Vesting Schedule; provided, however, that, if, as of any vesting date, the number of shares underlying the vested portion of the Option exceeds the number of shares available for issuance under the Plan (based on the then-current stockholder-approved share reserve thereunder (the EIP Reserve) and the number of shares subject to outstanding Stock Awards (as defined in the Plan) that were granted prior to the Grant Date specified above), then as to such excess shares, the Option shall not be exercisable until further stockholder approval is obtained for an adequate increase in the EIP Reserve.

Footnote F2

Subject to the terms of the Option Agreement, one-twelfth (1/12th) of the shares subject to this option will vest on the last day of each calendar quarter following the Vesting Commencement Date, with the first vesting date being June 30, 2026, subject to your Continuous Service through each such vesting date, such that all shares subject to this option will be fully vested on March 31, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .